AAAAAA

   
Results: 1-15 |
Results: 15

Authors: Christodoulou, C Bafaloukos, D Kosmidis, P Samantas, E Bamias, A Papakostas, P Karabelis, A Bacoyiannis, C Skarlos, DV
Citation: C. Christodoulou et al., Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases, ANN ONCOL, 12(2), 2001, pp. 249-254

Authors: Fountzilas, G Tsavdaridis, D Kalogera-Fountzila, A Christodoulou, C Timotheadou, E Kalofonos, C Kosmidis, P Adamou, A Papakostas, P Gogas, H Stathopoulos, G Razis, E Bafaloukos, D Skarlos, D
Citation: G. Fountzilas et al., Weekly paclitaxel as first-line chemotherapy and trastuzumab in patients with advanced breast cancer - A Hellenic Cooperative Oncology Group phase IIstudy, ANN ONCOL, 12(11), 2001, pp. 1545-1551

Authors: Pectasides, D Aravantinos, G Kalofonos, H Kiamouris, C Bafaloukos, D Xiros, N Nicolaides, C Visvikis, A Dimopoulos, MA
Citation: D. Pectasides et al., Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group, ANN ONCOL, 12(10), 2001, pp. 1417-1422

Authors: Razis, E Dimopoulus, AM Bafaloukos, D Papadimitriou, C Kalogera-Fountzila, A Kalofonos, H Briassoulis, E Samantas, E Keramopoulos, A Pavlidis, N Kosmidis, P Fountzilas, G
Citation: E. Razis et al., Dose-dense sequential chemotherapy with epirubicin and paclitaxel in advanced breast cancer, CANCER INV, 19(2), 2001, pp. 137-144

Authors: Fountzilas, G Papadimitriou, C Dafni, U Bafaloukos, D Skarlos, D Moulopouos, LA Razis, E Kalofonos, HP Aravantinos, G Briassoulis, E Papakostas, P Abela, K Gogas, E Kosmidis, P Pavlidis, N Dimopoulos, MA
Citation: G. Fountzilas et al., Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: A randomized study conducted by the Hellenic Cooperative Oncology Group, J CL ONCOL, 19(8), 2001, pp. 2232-2239

Authors: Brountzos, EN Panagiotou, IE Bafaloukos, D Magoulas, D Kelekis, DA
Citation: En. Brountzos et al., Malignant fibrous histiocytoma of the trunk metastatic to the liver - Treatment with transcatheter intrahepatic chemoembolization, AM J CL ONC, 24(4), 2001, pp. 370-371

Authors: Fountzilas, G Papadimitriou, C Aravantinos, G Nicolaides, C Stathopoulos, G Bafaloukos, D Kalofonos, H Ekonomopoulos, T Skarlos, D Pavlidis, N Dimopoulos, AM
Citation: G. Fountzilas et al., Dose-dense sequential adjuvant chemotherapy with epirubicin, paclitaxel and CMF in high-risk breast cancer, ONCOL-BASEL, 60(3), 2001, pp. 214-220

Authors: Samonis, G Thomakos, N Liakakos, T Macheras, A Mandrekas, D Kanavaki, S Bafaloukos, D Maraki, S
Citation: G. Samonis et al., Effects of cefepime and meropenem on the gastrointestinal colonization of surgical patients by Candida albicans, CHEMOTHERA, 47(5), 2001, pp. 350-353

Authors: Nicolaides, C Dimopoulos, MA Samantas, E Bafaloukos, D Kalofonos, C Fountzilas, G Razi, E Kosmidis, P Pavlidis, N
Citation: C. Nicolaides et al., Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: A phase II study conducted by the Hellenic Cooperative Oncology Group, ANN ONCOL, 11(7), 2000, pp. 873-875

Authors: Aravantinos, G Dimopoulos, MA Kosmidis, P Bafaloukos, D Papadimitriou, C Kiamouris, C Pavlidis, N Sikiotis, K Papakostas, P Skarlos, DV
Citation: G. Aravantinos et al., Ifosfamide plus oral etoposide salvage chemotherapy for platinum-resistantpaclitaxel-pretreated ovarian cancer, ANN ONCOL, 11(5), 2000, pp. 607-612

Authors: Fountzilas, G Nicolaides, C Bafaloukos, D Kalogera-Fountzila, A Kalofonos, H Samelis, G Aravantinos, G Pavlidis, N
Citation: G. Fountzilas et al., Docetaxel and gemcitabine in anthracycline-resistant advanced breast cancer: A Hellenic cooperative oncology group phase II study, CANCER INV, 18(6), 2000, pp. 503-509

Authors: Briasoulis, E Kalofonos, H Bafaloukos, D Samantas, E Fountzilas, G Xiros, N Skarlos, D Christodoulou, C Kosmidis, F Pavlidis, N
Citation: E. Briasoulis et al., Carboplatin plus paclitaxel in unknown primary carcinoma: A phase II Hellenic Cooperative Oncology Group study, J CL ONCOL, 18(17), 2000, pp. 3101-3107

Authors: Janinis, J Giannakakis, T Athanasiades, A Fountzilas, G Bafaloukos, D Kosmidis, P Nikolaides, K Pavlidis, N Skarlos, D
Citation: J. Janinis et al., A randomized open-label parallel-group study comparing ondansetron with ondansetron plus dexamethasone in patients with metastatic breast cancer receiving high-dose epirubicin. A Hellenic Cooperative Oncology Group study, TUMORI, 86(1), 2000, pp. 37-41

Authors: Aravantinos, G Skarlos, DV Kosmidis, P Georgoulias, V Sgouros, I Bafaloukos, D Androulakis, N Florou, S Fountzilas, G
Citation: G. Aravantinos et al., Irinotecan (CPT-11) in patients with advanced colorectal cancer previouslytreated with 5-fluorouracil-based chemotherapy, CR R ONC H, 32(3), 1999, pp. 209-219

Authors: Bafaloukos, D Aravantinos, G Samonis, G Katsifis, G Bakoyiannis, C Skarlos, D Kosmidis, P
Citation: D. Bafaloukos et al., Carboplatin, methotrexate and 5-fluorouracil in combination with medroxyprogesterone acetate (JMF-M) in the treatment of advanced or recurrent endometrial carcinoma: A Hellenic Cooperative Oncology Group Study, ONCOL-BASEL, 56(3), 1999, pp. 198-201
Risultati: 1-15 |